Top

Published in:

Open Access 01-07-2011 | Original Contribution

Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction

Authors: Michael Lichtenauer, Michael Mildner, Andrea Baumgartner, Matthias Hasun, Gregor Werba, Lucian Beer, Patrick Altmann, Georg Roth, Mariann Gyöngyösi, Bruno Karl Podesser, Hendrik Jan Ankersmit

Published in: Basic Research in Cardiology | Issue 4/2011

Abstract

Congestive heart failure developing after acute myocardial infarction (AMI) is a major cause of morbidity and mortality. Clinical trials of cell-based therapy after AMI evidenced only a moderate benefit. We could show previously that suspensions of apoptotic peripheral blood mononuclear cells (PBMC) are able to reduce myocardial damage in a rat model of AMI. Here we experimentally examined the biochemical mechanisms involved in preventing ventricular remodelling and preserving cardiac function after AMI. Cell suspensions of apoptotic cells were injected intravenously or intramyocardially after experimental AMI induced by coronary artery ligation in rats. Administration of cell culture medium or viable PBMC served as controls. Immunohistological analysis was performed to analyse the cellular infiltrate in the ischaemic myocardium. Cardiac function was quantified by echocardiography. Planimetry of the infarcted hearts showed a significant reduction of infarction size and an improvement of post AMI remodelling in rats treated with suspensions of apoptotic PBMC (injected either intravenously or intramoycardially). Moreover, these hearts evidenced enhanced homing of macrophages and cells staining positive for c-kit, FLK-1, IGF-I and FGF-2 as compared to controls. A major finding in this study further was that the ratio of elastic and collagenous fibres within the scar tissue was altered in a favourable fashion in rats injected with apoptotic cells. Intravenous or intramyocardial injection of apoptotic cell suspensions results in attenuation of myocardial remodelling after experimental AMI, preserves left ventricular function, increases homing of regenerative cells and alters the composition of cardiac scar tissue. The higher expression of elastic fibres provides passive energy to the cardiac scar tissue and results in prevention of ventricular remodelling.

Available only for authorised users

Ankersmit HJ, Hoetzenecker K, Dietl W, Soleiman A, Horvat R, Wolfsberger M, Gerner C, Hacker S, Mildner M, Moser B, Lichtenauer M, Podesser BK (2009) Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest 39:445–456. doi:10.1111/j.1365-2362.2009.02111.x PubMedCrossRef

Arras M, Strasser R, Mohri M, Doll R, Eckert P, Schaper W, Schaper J (1998) Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol 93:97–107. doi:10.1007/s003950050069 PubMedCrossRef

Beitnes JO, Hopp E, Lunde K, Solheim S, Arnesen H, Brinchmann JE, Forfang K, Aakhus S (2009) Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart 95:1983–1989. doi:10.1136/hrt.2009.178913 PubMedCrossRef

Bittencourt MC, Perruche S, Contassot E, Fresnay S, Baron MH, Angonin R, Aubin F, Hervé P, Tiberghien P, Saas P (2001) Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 98:224–230. doi:10.1182/blood.V98.1.224 PubMedCrossRef

Breivik L, Helgeland E, Aarnes EK, Mrdalj J, Jonassen AK (2011) Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion. Basic Res Cardiol 106:135–145. doi:10.1007/s00395-010-0133-0 PubMedCrossRef

Bush CA, Renner W, Boudoulas H (1980) Corticosteroids in acute myocardial infarction. Angiology 31:710–714. doi:10.1177/000331978003101007 PubMedCrossRef

Cantor WJ, Ohman EM (1999) Results of recent large myocardial infarction trials, adjunctive therapies, and acute myocardial infarction: improving outcomes. Cardiol Rev 7:232–244. doi:10.1061/5377/99/704-232/0 PubMedCrossRef

Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus HA, Frey N (2010) FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res Cardiol 105:301–313. doi:10.1007/s00395-009-0046-y PubMedCrossRef

Cimini M, Fazel S, Zhuo S, Xaymardan M, Fujii H, Weisel RD, Li RK (2007) c-kit dysfunction impairs myocardial healing after infarction. Circulation 116:I77–I82. doi:10.1161/CIRCULATIONAHA.107.708107 PubMedCrossRef

10.

Conn KJ, Rich CB, Jensen DE, Fontanilla MR, Bashir MM, Rosenbloom J, Foster JA (1996) Insulin-like growth factor-I regulates transcription of the elastin gene through a putative retinoblastoma control element. A role for Sp3 acting as a repressor of elastin gene transcription. J Biol Chem 271:28853–28860. doi:10.1074/jbc.271.46.28853 PubMedCrossRef

11.

Di Santo S, Yang Z, Wyler von Ballmoos M, Voelzmann J, Diehm N, Baumgartner I, Kalka C (2009) Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One 4:e5643. doi:10.1371/journal.pone.0005643 PubMedCrossRef

12.

Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK (2006) Cardioprotective c-kit + cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 116:1865–1877. doi:10.1172/JCI27019 PubMedCrossRef

13.

Fazel SS, Chen L, Angoulvant D, Li SH, Weisel RD, Keating A, Li RK (2008) Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury. FASEB J 22:930–940. doi:10.1096/fj.07-8636com PubMedCrossRef

14.

Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109:625–637. doi:10.1016/S0092-8674(02)00754-7 PubMedCrossRef

15.

Heusch G, Kleinbongard P, Böse D, Levkau B, Haude M, Schulz R, Erbel R (2009) Coronary Microembolization: from bedside to bench and back to bedside. Circulation 120:1822–1836. doi:10.1161/CIRCULATIONAHA.109.888784 PubMedCrossRef

16.

Hoffmann PR, Kench JA, Vondracek A, Kruk E, Daleke DL, Jordan M, Marrack P, Henson PM, Fadok VA (2005) Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol 174:1393–1404PubMed

17.

Huynh ML, Fadok VA, Henson PM (2002) Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109:41–50. doi:10.1172/JCI0211638 PubMed

18.

Kadl A, Huber J, Gruber F, Bochkov VN, Binder BR, Leitinger N (2002) Analysis of inflammatory gene induction by oxidized phospholipids in vivo by quantitative real-time RT-PCR in comparison with effects of LPS. Vascul Pharmacol 38:219–227. doi:10.1016/S1537-1891(02)00172-6 PubMedCrossRef

19.

Kleinbongard P, Heusch G, Schulz R (2010) TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 127:295–314. doi:10.1016/j.pharmthera.2010.05.002 PubMedCrossRef

20.

Kocher AA, Schuster MD, Bonaros N, Lietz K, Xiang G, Martens TP, Kurlansky PA, Sondermeijer H, Witkowski P, Boyle A, Homma S, Wang SF, Itescu S (2006) Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol 40:455–464. doi:10.1016/j.yjmcc.2005.11.013 PubMedCrossRef

21.

Kothapalli CR, Ramamurthi A (2008) Benefits of concurrent delivery of hyaluronan and IGF-1 cues to regeneration of crosslinked elastin matrices by adult rat vascular cells. J Tissue Eng Regen Med 2:106–116. doi:10.1002/term.70 PubMedCrossRef

22.

Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB, Eichwald E, Keating MT (1998) Elastin is an essential determinant of arterial morphogenesis. Nature 393:276–280. doi:10.1038/30522 PubMedCrossRef

23.

Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355:1199–1209. doi:10.1056/NEJMoa055706 PubMedCrossRef

24.

Matthews KG, Devlin GP, Conaglen JV, Stuart SP, Mervyn Aitken W, Bass JJ (1999) Changes in IGFs in cardiac tissue following myocardial infarction. J Endocrinol 163:433–445. doi:10.1677/joe.0.1630433 PubMedCrossRef

25.

Mersmann J, Habeck K, Latsch K, Zimmermann R, Jacoby C, Fischer JW, Hartmann C, Schrader J, Kirschning CJ, Zacharowski K (2011) Left ventricular dilation in toll-like receptor 2 deficient mice after myocardial ischemia/reperfusion through defective scar formation. Basic Res Cardiol 106:89–98. doi:10.1007/s00395-010-0127-y PubMedCrossRef

26.

Meyer GP, Wollert KC, Lotz J, Pirr J, Rager U, Lippolt P, Hahn A, Fichtner S, Schaefer A, Arseniev L, Ganser A, Drexler H (2009) Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 30:2978–2984. doi:10.1093/eurheartj/ehp374 PubMedCrossRef

27.

Mizuno T, Yau TM, Weisel RD, Kiani CG, Li RK (2005) Elastin stabilizes an infarct and preserves ventricular function. Circulation 112:I81–I88. doi:10.1161/01.CIRCULATIONAHA.105.523795 PubMedCrossRef

28.

Mizuno T, Mickle DA, Kiani CG, Li RK (2005) Overexpression of elastin fragments in infarcted myocardium attenuates scar expansion and heart dysfunction. Am J Physiol Heart Circ Physiol 288:H2819–H2827. doi:10.1152/ajpheart.00862.2004 PubMedCrossRef

29.

Möllmann H, Nef HM, Kostin S, von Kalle C, Pilz I, Weber M, Schaper J, Hamm CW, Elsässer A (2006) Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res 71:661–671. doi:10.1016/j.cardiores.2006.06.013 PubMedCrossRef

30.

Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98:10344–10349. doi:10.1073/pnas.181177898 PubMedCrossRef

31.

Perruche S, Kleinclauss F, Bittencourt Mde C, Paris D, Tiberghien P, Saas P (2004) Intravenous infusion of apoptotic cells simultaneously with allogenic hematopoietic grafts alters anti-donor humoral immune responses. Am J Transplant 4:1361–1365. doi:10.1111/j.1600-6143.2004.00509.x PubMedCrossRef

32.

Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. doi:10.1093/nar/29.9.e45 PubMedCrossRef

33.

Pfeffer MA, Braunwald E (1990) Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81:1161–1672PubMed

34.

Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210–1221. doi:10.1056/NEJMoa060186 PubMedCrossRef

35.

Schuh A, Liehn EA, Sasse A, Schneider R, Neuss S, Weber C, Kelm M, Merx MW (2009) Improved left ventricular function after transplantation of microspheres and fibroblasts in a rat model of myocardial infarction. Basic Res Cardiol 104:403–411. doi:10.1007/s00395-008-0763-7 PubMedCrossRef

36.

Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, Heusch G (2007) Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 100:140–146. doi:10.1161/01.RES.0000255031.15793.86 PubMedCrossRef

37.

Sun E, Gao Y, Chen J, Roberts AI, Wang X, Chen Z et al (2004) Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient. Cell Death Differ 11:1258–1264PubMedCrossRef

38.

Thum T, Bauersachs J, Poole-Wilson PA, Volk HD, Anker SD (2005) The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 46:1799–1802. doi:10.1016/j.jacc.2005.07.053 PubMedCrossRef

39.

Tremblay J, Chen H, Peng J, Kunes J, Vu MD, Der Sarkissian S, deBlois D, Bolton AE, Gaboury L, Marshansky V, Gouadon E, Hamet P (2002) Renal ischemia-reperfusion injury in the rat is prevented by a novel immune modulation therapy. Transplantation 74:1425–1433. doi:10.1097/01.TP.0000034208.20704.E1 PubMedCrossRef

40.

Valeur HS, Valen G (2009) Innate immunity and myocardial adaptation to ischemia. Basic Res Cardiol 104:22–32. doi:10.1007/s00395-008-0756-6 PubMedCrossRef

41.

Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D’Agostino RB, Levy D, Kannel WB, Vasan RS (2008) Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 118:2057–2062. doi:10.1161/CIRCULATIONAHA.108.784215 PubMedCrossRef

42.

Virag JA, Rolle ML, Reece J, Hardouin S, Feigl EO, Murry CE (2007) Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function. Am J Pathol 171:1431–1440. doi:10.2353/ajpath.2007.070003 PubMedCrossRef

43.

Wolfe BL, Rich CB, Goud HD, Terpstra AJ, Bashir M, Rosenbloom J, Sonenshein GE, Foster JA (1993) Insulin-like growth factor-I regulates transcription of the elastin gene. J Biol Chem 268:12418–12426PubMed

44.

Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141–148. doi:10.1016/S0140-6736(04)16626-9 PubMedCrossRef

Title: Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction
Authors: Michael Lichtenauer
Michael Mildner
Andrea Baumgartner
Matthias Hasun
Gregor Werba
Lucian Beer
Patrick Altmann
Georg Roth
Mariann Gyöngyösi
Bruno Karl Podesser
Hendrik Jan Ankersmit
Publication date: 01-07-2011
Publisher: Springer-Verlag
Published in: Basic Research in Cardiology / Issue 4/2011
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-011-0173-0

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2011

Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation?

Activated NHE1 is required to induce early cardiac hypertrophy in mice

Acute vasomotor paralysis and potential downstream effects of paclitaxel from stents implanted for saphenous vein aorto-coronary bypass stenosis

Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutase

The alpha1 isoform of soluble guanylate cyclase regulates cardiac contractility but is not required for ischemic preconditioning

Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page